Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Plasma melatonin is reduced in Huntington's disease.

Identifieur interne : 000474 ( Main/Exploration ); précédent : 000473; suivant : 000475

Plasma melatonin is reduced in Huntington's disease.

Auteurs : Eirini Kalliolia [Royaume-Uni] ; Edina Silajdži ; Rajasree Nambron ; Nathan R. Hill ; Anisha Doshi ; Chris Frost ; Hilary Watt ; Peter Hindmarsh ; Maria Björkqvist ; Thomas T. Warner

Source :

RBID : pubmed:25164424

English descriptors

Abstract

This study was undertaken to determine whether the production of melatonin, a hormone regulating sleep in relation to the light/dark cycle, is altered in Huntington's disease. We analyzed the circadian rhythm of melatonin in a 24-hour study of cohorts of control, premanifest, and stage II/III Huntington's disease subjects. The mean and acrophase melatonin concentrations were significantly reduced in stage II/III Huntington's disease subjects compared with controls. We also observed a nonsignificant trend toward reduced mean and acrophase melatonin in premanifest Huntington's disease subjects. Onset of melatonin rise was significantly more temporally spread in both premanifest and stage II/III Huntington's disease subjects compared with controls. A nonsignificant trend also was seen for reduced pulsatile secretion of melatonin. Melatonin concentrations are reduced in Huntington's disease. Altered melatonin patterns may provide an explanation for disrupted sleep and circadian behavior in Huntington's disease, and represent a biomarker for disease state. Melatonin therapy may help the sleep disorders seen in Huntington's disease.

DOI: 10.1002/mds.26003
PubMed: 25164424


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Plasma melatonin is reduced in Huntington's disease.</title>
<author>
<name sortKey="Kalliolia, Eirini" sort="Kalliolia, Eirini" uniqKey="Kalliolia E" first="Eirini" last="Kalliolia">Eirini Kalliolia</name>
<affiliation wicri:level="3">
<nlm:affiliation>Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences, UCL Institute of Neurology, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences, UCL Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Silajdzi, Edina" sort="Silajdzi, Edina" uniqKey="Silajdzi E" first="Edina" last="Silajdži">Edina Silajdži</name>
</author>
<author>
<name sortKey="Nambron, Rajasree" sort="Nambron, Rajasree" uniqKey="Nambron R" first="Rajasree" last="Nambron">Rajasree Nambron</name>
</author>
<author>
<name sortKey="Hill, Nathan R" sort="Hill, Nathan R" uniqKey="Hill N" first="Nathan R" last="Hill">Nathan R. Hill</name>
</author>
<author>
<name sortKey="Doshi, Anisha" sort="Doshi, Anisha" uniqKey="Doshi A" first="Anisha" last="Doshi">Anisha Doshi</name>
</author>
<author>
<name sortKey="Frost, Chris" sort="Frost, Chris" uniqKey="Frost C" first="Chris" last="Frost">Chris Frost</name>
</author>
<author>
<name sortKey="Watt, Hilary" sort="Watt, Hilary" uniqKey="Watt H" first="Hilary" last="Watt">Hilary Watt</name>
</author>
<author>
<name sortKey="Hindmarsh, Peter" sort="Hindmarsh, Peter" uniqKey="Hindmarsh P" first="Peter" last="Hindmarsh">Peter Hindmarsh</name>
</author>
<author>
<name sortKey="Bjorkqvist, Maria" sort="Bjorkqvist, Maria" uniqKey="Bjorkqvist M" first="Maria" last="Björkqvist">Maria Björkqvist</name>
</author>
<author>
<name sortKey="Warner, Thomas T" sort="Warner, Thomas T" uniqKey="Warner T" first="Thomas T" last="Warner">Thomas T. Warner</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25164424</idno>
<idno type="pmid">25164424</idno>
<idno type="doi">10.1002/mds.26003</idno>
<idno type="wicri:Area/PubMed/Corpus">000405</idno>
<idno type="wicri:Area/PubMed/Curation">000405</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000478</idno>
<idno type="wicri:Area/Ncbi/Merge">004098</idno>
<idno type="wicri:Area/Ncbi/Curation">004098</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004098</idno>
<idno type="wicri:Area/Main/Merge">000474</idno>
<idno type="wicri:Area/Main/Curation">000474</idno>
<idno type="wicri:Area/Main/Exploration">000474</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Plasma melatonin is reduced in Huntington's disease.</title>
<author>
<name sortKey="Kalliolia, Eirini" sort="Kalliolia, Eirini" uniqKey="Kalliolia E" first="Eirini" last="Kalliolia">Eirini Kalliolia</name>
<affiliation wicri:level="3">
<nlm:affiliation>Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences, UCL Institute of Neurology, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences, UCL Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Silajdzi, Edina" sort="Silajdzi, Edina" uniqKey="Silajdzi E" first="Edina" last="Silajdži">Edina Silajdži</name>
</author>
<author>
<name sortKey="Nambron, Rajasree" sort="Nambron, Rajasree" uniqKey="Nambron R" first="Rajasree" last="Nambron">Rajasree Nambron</name>
</author>
<author>
<name sortKey="Hill, Nathan R" sort="Hill, Nathan R" uniqKey="Hill N" first="Nathan R" last="Hill">Nathan R. Hill</name>
</author>
<author>
<name sortKey="Doshi, Anisha" sort="Doshi, Anisha" uniqKey="Doshi A" first="Anisha" last="Doshi">Anisha Doshi</name>
</author>
<author>
<name sortKey="Frost, Chris" sort="Frost, Chris" uniqKey="Frost C" first="Chris" last="Frost">Chris Frost</name>
</author>
<author>
<name sortKey="Watt, Hilary" sort="Watt, Hilary" uniqKey="Watt H" first="Hilary" last="Watt">Hilary Watt</name>
</author>
<author>
<name sortKey="Hindmarsh, Peter" sort="Hindmarsh, Peter" uniqKey="Hindmarsh P" first="Peter" last="Hindmarsh">Peter Hindmarsh</name>
</author>
<author>
<name sortKey="Bjorkqvist, Maria" sort="Bjorkqvist, Maria" uniqKey="Bjorkqvist M" first="Maria" last="Björkqvist">Maria Björkqvist</name>
</author>
<author>
<name sortKey="Warner, Thomas T" sort="Warner, Thomas T" uniqKey="Warner T" first="Thomas T" last="Warner">Thomas T. Warner</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Fourier Analysis</term>
<term>Humans</term>
<term>Huntington Disease (blood)</term>
<term>Male</term>
<term>Melatonin (blood)</term>
<term>Middle Aged</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Melatonin</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en">
<term>Huntington Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Fourier Analysis</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">This study was undertaken to determine whether the production of melatonin, a hormone regulating sleep in relation to the light/dark cycle, is altered in Huntington's disease. We analyzed the circadian rhythm of melatonin in a 24-hour study of cohorts of control, premanifest, and stage II/III Huntington's disease subjects. The mean and acrophase melatonin concentrations were significantly reduced in stage II/III Huntington's disease subjects compared with controls. We also observed a nonsignificant trend toward reduced mean and acrophase melatonin in premanifest Huntington's disease subjects. Onset of melatonin rise was significantly more temporally spread in both premanifest and stage II/III Huntington's disease subjects compared with controls. A nonsignificant trend also was seen for reduced pulsatile secretion of melatonin. Melatonin concentrations are reduced in Huntington's disease. Altered melatonin patterns may provide an explanation for disrupted sleep and circadian behavior in Huntington's disease, and represent a biomarker for disease state. Melatonin therapy may help the sleep disorders seen in Huntington's disease.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement>
<li>Londres</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Bjorkqvist, Maria" sort="Bjorkqvist, Maria" uniqKey="Bjorkqvist M" first="Maria" last="Björkqvist">Maria Björkqvist</name>
<name sortKey="Doshi, Anisha" sort="Doshi, Anisha" uniqKey="Doshi A" first="Anisha" last="Doshi">Anisha Doshi</name>
<name sortKey="Frost, Chris" sort="Frost, Chris" uniqKey="Frost C" first="Chris" last="Frost">Chris Frost</name>
<name sortKey="Hill, Nathan R" sort="Hill, Nathan R" uniqKey="Hill N" first="Nathan R" last="Hill">Nathan R. Hill</name>
<name sortKey="Hindmarsh, Peter" sort="Hindmarsh, Peter" uniqKey="Hindmarsh P" first="Peter" last="Hindmarsh">Peter Hindmarsh</name>
<name sortKey="Nambron, Rajasree" sort="Nambron, Rajasree" uniqKey="Nambron R" first="Rajasree" last="Nambron">Rajasree Nambron</name>
<name sortKey="Silajdzi, Edina" sort="Silajdzi, Edina" uniqKey="Silajdzi E" first="Edina" last="Silajdži">Edina Silajdži</name>
<name sortKey="Warner, Thomas T" sort="Warner, Thomas T" uniqKey="Warner T" first="Thomas T" last="Warner">Thomas T. Warner</name>
<name sortKey="Watt, Hilary" sort="Watt, Hilary" uniqKey="Watt H" first="Hilary" last="Watt">Hilary Watt</name>
</noCountry>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Kalliolia, Eirini" sort="Kalliolia, Eirini" uniqKey="Kalliolia E" first="Eirini" last="Kalliolia">Eirini Kalliolia</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000474 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000474 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25164424
   |texte=   Plasma melatonin is reduced in Huntington's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25164424" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024